Molbio Diagnostics Ltd IPO
MainboardPrice Band
₹768-807
Issue Size
₹939.7 Cr
Lot Size
18
Open Date
10 Aug 2026
Close Date
12 Aug 2026
Listing Date
17 Aug 2026
This IPO is Closed
Molbio Diagnostics Ltd IPO Timeline
Track key IPO dates — from opening and closing to allotment, refund, and listing.
IPO Open Date
10 Aug 2026
IPO Close Date
12 Aug 2026
Allotment Date
13 Aug 2026
Refund Date
14 Aug 2026
Credit to Demat
14 Aug 2026
Listing Date
17 Aug 2026
Molbio Diagnostics Ltd IPO Subscription Status
See how the issue is being subscribed across QIB, NII, Retail, and Employee categories.
| Date | QIB | NII | RII | Employee | Total |
|---|---|---|---|---|---|
| 10 Aug 2026 | 1.00x | 0.73x | 0.77x | 2.12x | 0.83x |
| 11 Aug 2026 | 1.39x | 5.21x | 3.18x | 4.78x | 3.11x |
| 12 Aug 2026 | 186.39x | 49.80x | 12.96x | 13.28x | 70.26x |
Molbio Diagnostics Ltd IPO Financials
A quick look at revenue, EBITDA, profit, and net worth over the last three years.
| Year | Total Revenue (Cr) | EBITDA (Cr) | PAT (Cr) | Networth (Cr) | EPS (₹) |
|---|---|---|---|---|---|
| FY26-03 | 1321.11 | 256.44 | 144.63 | 1134.71 | 12.83 |
| FY25-03 | 977.60 | 223.21 | 139.82 | 990.07 | 12.40 |
| FY24-03 | 762.84 | 183.09 | 111.11 | 849.98 | 9.86 |
Molbio Diagnostics Ltd IPO Strengths
- We are well placed to address unmet demand in a large and growing molecular diagnostic market with gaining credence of point-of-care testing.
- Innovative, R&D focussed business.
- We have developed and commercialized a novel portable multi-disease point-of-care molecular diagnostics platform.
- We have a scalable business model with strong entry barriers, high proportion of recurring revenues and a growing suite of tests.
- Our strategic collaborations and acquisitions enhance our capabilities and offerings.
- We have a management team with deep domain expertise and track record of delivering strong financial performance.
Molbio Diagnostics Ltd IPO Reservation
See what share of the issue is reserved for Retail, QIB, NII, and Anchor investors.
| Category | Shares Offered | % of Total |
|---|---|---|
| Retail | 40,69,005 | 34.94% |
| QIB | 23,25,146 | 19.96% |
| NII / HNI | 17,43,859 | 14.97% |
| Anchor Investors | 34,87,717 | 29.95% |
| Employees | 20,519 | 0.18% |
| Total | 1,16,46,246 | 100% |
Molbio Diagnostics Ltd Registrar & Company Details
Registrar
KFin Techologies Ltd
Karvy Selenium Tow-B, 31&32 Financial Dist, Nanakramguda, Hyderabad-500032
+91 40 6716 2222
molbio.ipo@kfintech.com
www.kfintech.com
Company
Molbio Diagnostics Ltd
No.L-46 Phase II-D, Verna Industrial Area Verna, Salcete, 403722
+91 832 6724 888
investors@molbiodiagnostics.com
CIN: U33125GA2000PLC002909
http://www.molbiodiagnostics.com
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
The Molbio Diagnostics Ltd IPO has an issue size of ₹939.7 crore.
The minimum investment required for the Molbio Diagnostics Ltd IPO is ₹14,526, based on a minimum lot size of 18 shares and the applicable IPO price.
The lot size for the Molbio Diagnostics Ltd IPO is 18 shares.
The allotment for the Molbio Diagnostics Ltd IPO is scheduled for 13 Aug 2026.
Investors can check the Molbio Diagnostics Ltd IPO allotment status using their PAN, application number, or other required details through the IPO registrar's website or the relevant stock exchange website.
The registrar for the Molbio Diagnostics Ltd IPO is KFin Techologies Ltd.
The Molbio Diagnostics Ltd IPO opens on 10 Aug 2026 and closes on 12 Aug 2026.
You can apply for the IPO through Anand Rathi using the applicable IPO application process:
Note: Investors are requested to do their own due diligence before investing in any IPO.
The Molbio Diagnostics Ltd IPO is scheduled to be listed on 17 Aug 2026 on BSE,NSE.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
